Chapter 35 HIV-associated malignancies Ronald T. Mitsuyasu Introduction Malignancies have been a well-recognized manifestation of AIDS since the beginning of the epidemic. The increased incidence of aggressive B-cell non-Hodgkin’s lymphoma…
Chapter 8 The design of a global HIV vaccine1 Jerome H. Kim, Nelson L. Michael Since our first knowledge of the HIV-1 epidemic in 1981 it is estimated that over…
Chapter 20 Psychiatric barriers and the international AIDS epidemic Chiadi U. Onyike, Andrew F. Angelino, Glenn J. Treisman Introduction The analysis of causation and intervention in the HIV/AIDS epidemic has…
Chapter 28 Candida in HIV infection William G. Powderly Epidemiology Candidiasis is caused by fungi of the Candida species, which are yeasts that are ubiquitous in the environment. Candida species…
Chapter 25 Other HIV-related pneumonias John G. Bartlett Introduction The lower respiratory tract has been and continues to be a major site of opportunistic infections in patients with HIV infection….
Chapter 31 AIDS-associated toxoplasmosis Pablo A. Moncada, Jose G. Montoya Introduction and Epidemiology Toxoplasma gondii is among the most prevalent causes of latent infection of the central nervous system (CNS)…
Chapter 2 The origins and diversification of HIV Michael Worobey, Guan-Zhu Han Introduction Human immunodeficiency virus (HIV) is not one but several related viruses that have crossed into the human…
Chapter 22 Endocrine complications of HIV infection Steven A. Taylor, Carl Grunfeld, Morris Schambelan Introduction A wide spectrum of endocrine complications is associated with HIV infection and AIDS. Although these…
Chapter 5 Viral and host determinants of HIV-1 disease progression Daniëlle van Manen, Angélique B. van ‘t Wout, Hanneke Schuitemaker Introduction The clinical course of HIV-1 infection can be highly…
Chapter 19 Primary neurological manifestation of HIV/AIDS David B. Clifford, Mengesha A. Teshome Introduction In the past 30 years we have learned much about the biology and treatment of human…
